SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as investors react to positive expansion momentum, analyst buy ratings, and anticipation surrounding upcoming earnings. The community is actively debating the company's valuation, potential relisting prospects, and its competitive stance against rivals in both domestic and international markets.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund (USO) is experiencing high volatility as the market reacts to conflicting reports of diplomatic negotiations versus escalating military tensions in the Strait of Hormuz. Community discussion is heavily focused on the disconnect between official administration statements about potential peace deals and the ongoing supply-chain disruptions, with many investors debating whether to hedge against further geopolitical instability or capitalize on sharp price swings driven by algorithmic trading.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is experiencing renewed investor interest and upward momentum driven by the successful EU approval of its oral Wegovy pill, which is positioned to challenge competitors by removing the need for injections. The market is actively weighing the company's strong early adoption data against ongoing legal maneuvers with Eli Lilly, while long-term investors remain focused on the company's manufacturing scale and its potential to capture a larger share of the expanding obesity and diabetes treatment market.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is trending heavily as investors speculate on a major anchor tenant deal, with community discussion centered on a significant executive performance incentive that creates a clear deadline for a contract announcement. While the stock has seen high volatility due to a recent convertible note offering, many participants are actively accumulating shares, viewing the current price action as a strategic opportunity before the potential for a major catalyst.

Ambarella, Inc. engages in the development of low-power system-on-a-chip (SoC), semiconductors, and software for edge artificial intelligence (AI) applications and intelligent automation. The firm's products include video security, advanced driver assistance (ADAS), electronic mirror, drive recorder, driver or cabin monitoring, autonomous driving, and other robotics applications. It operates through the following geographical segments: Taiwan, Asia Pacific, Europe, North America, and United States. The company was founded by Feng Ming Wang and Leslie D. Kohn on January 15, 2004 and is headquartered in Santa Clara, CA.

Ambarella Inc

Ambarella shares are surging as investors react to reports of potential acquisition interest from NXP Semiconductors, a move seen as a strategic play to bolster NXP's presence in edge AI and automotive vision technology. While the community is debating the potential takeover premium, some traders are expressing skepticism regarding the deal's viability, keeping a close watch on potential counter-bidders and overall volatility.

Whirlpool Corp. engages in the manufacturing and marketing of home appliances. Its products include home laundry appliances, refrigerators and freezers, cooking appliances, home dishwashers, and room air-conditioning equipment, mixers, and portable household appliances. The firm's brands include Whirlpool, KitchenAid, Maytag, Consul, Brastemp, Amana, Bauknecht, JennAir, and Indesit. It operates through the following geographical segments: Major Domestic Appliances (MDA) North America, Major Domestic Appliances (MDA) Latin America, Small Domestic Appliances (SDA) Global, and Others. The company was founded by Emory Upton, Fred Upton, and Louis C. Upton on November 11, 1911 and is headquartered in Benton Harbor, MI.

Whirlpool Corp.

Whirlpool is facing significant market volatility as investors weigh disappointing earnings results, a surprise dividend suspension, and ongoing strategic shifts aimed at aggressive debt reduction. Community sentiment is deeply divided, with many traders discussing potential bankruptcy risks while contrarian investors speculate on long-term value opportunities amid the stock's multi-year lows.

Jersey Mike's Subs, Inc. engages in franchising fast casual, submarine-style sandwich restaurants specializing in authentic, hand-crafted, and craveable subs. The company was founded by Peter Cancro in 1956 and is headquartered in Tinton Falls, DE.

Jersey Mike`s Subs Inc. - Ordinary Shares - Class A

Jersey Mike's Subs recently made its public market debut on the NYSE, sparking intense debate among investors over its valuation and growth potential following a highly oversubscribed IPO. While some market participants are bullish on the company's aggressive expansion plans and brand loyalty, others are skeptical, citing concerns over pricing, competition in the fast-food space, and the influence of private equity ownership.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors react to the companys strategic repurchase of convertible debt and high-stakes anticipation surrounding potential near-term milestone payments and upcoming European regulatory news. The community is actively discussing these de-risking maneuvers against a backdrop of ongoing short interest, with many speculating that the company is clearing its balance sheet ahead of major commercial catalysts or a potential acquisition.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending amid intense investor frustration over stagnant price action and poor communication from leadership, despite the company's strong revenue profile and key commercial assets. The community is sharply divided between those betting on an upcoming recovery through pipeline catalysts and those arguing the stock remains severely undervalued relative to its sector peers.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is seeing intense community discussion surrounding the company's potential as a buyout target, driven by the strong commercial performance of its flagship drug, Carvykti, and the ongoing expansion of its in vivo CAR-T pipeline. Investors are closely monitoring leadership changes and the strategic implications of the company's partnership with J&J, with many speculating that a business development deal or full acquisition could occur in the near term.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Quantum X Labs Validates Continuous-Data Quantum Sampling Workflow and Achieves Significant GPU Acceleration with NVIDIA CUDA-Q

Others

12 Communication Services Stocks Moving In Monday's Pre-Market Session

Gainers

Fast Track Group (NASDAQ:FTRK) stock increased by 45.4% to $0.58 during Monday's pre-market session. The market value of their outstanding shares is at $8.6 million.
Quantum X Labs (NASDAQ:QXL) shares roseread more...

Quantum X Labs Appoints Leading Physics Engineering Expert to Advance its Quantum and Fault-Tolerant Quantum Computing Technologies

Zacks Initiates Coverage of Quantum X With Underperform Recommendation

Discover why Zacks issues an "Underperform" rating for QXL, being the first on Wall Street to initiate coverage on the stock. Learn why liquidity concerns, persistent losses, funding dependence and a weakening legacy business overshadow the company's promising quantum computing ambitions.


Quantum X Labs Launches Integrated Quantum Computing Program Combining Its Clinical Trials Data Analysis Quantum Algorithm and Its Quantum Error Correction Decoder

Quantum X Labs and IQCC, a Quantum Machines Company, Sign Strategic Collaboration Agreement to Evaluate AI-Based Quantum Error Correction on Quantum Infrastructure

This account has been verified as an official QXL representative.

Verified Account

Quantum X Labs

Quantum X Labs, Inc. engages in the provision of digital advertising platform that develops and markets a variety of technological platforms that automate, optimize, and monetize digital online campaigns. It operates through the Search and Digital Content segments. The Search segment focuses on developing technological software solutions that perform automation, optimization, and monetization of internet campaigns. The Digital Content segment refers to the creation and editing of content to generate revenues from advertising platforms such as Google, Facebook, Yahoo, and Apple. The company was founded by Lior Wayn on August 16, 1985 and is headquartered in Ramat Hachayal, Israel.

Quantum X Labs Inc.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$4.41
Prev Close	$4.50
Open	$4.87
Dividend Yield	0.00%
50-Day Moving Average	$4.98
Beta	-0.49
Avg. Volume	200,161.24
PE Ratio	-1.39

52-Week High	$7.70
52-Week Low	$0.9605
Market Capitalization	$60.01M
EPS (Annual)	-$1.58
Price to Book	2.78
Revenue Per Employee	$74,714.29

Feed

News

Sentiment

Fundamentals

Info